SHREES PHARMA PRIVATE LIMITED
SHREES PHARMA PRIVATE LIMITED is a KARNATAKA based PRIVATE LIMITED company, Registered at dated 09-DEC-2020 on Ministry of Corporate Affairs(MCA), The Corporate Identification Number (CIN) of SHREES PHARMA PRIVATE LIMITED is U24290KA2020PTC142000 and registration number is 142000.
It has been classified as COMPANY LIMITED BY SHARES and is registered under Registar of Companies ROC-BANGALORE India. Authorized share capital of SHREES PHARMA PRIVATE LIMITED is Rs. 100000 and its paid up capital is Rs. 100000. It aspire to serve in MANUFACTURE OF CHEMICALS AND CHEMICAL PRODUCTS activities across the India.
Its Annual General Meeting (AGM) was lastly conducted on and as per the records of Ministry of Corporate Affairs (MCA), its balance sheet was last filed on .
SHREES PHARMA PRIVATE LIMITED has 3 directors BASAVARAJ, RAVI KUMAR, SURESH,
The registered Email address of SHREES PHARMA PRIVATE LIMITED is basavaajrm135@gmail.com and its registered address is 12-10-92/1, GANDHI CHOWK SRRNO 4554 R2 T8 P4/A LINGASUGUR RAICHUR KA 584102 IN KARNATAKA KARNATAKA india 584102.
The current status of SHREES PHARMA PRIVATE LIMITED shows as ACTIVE
COMPANY BASIC DETAILS
SHREES PHARMA PRIVATE LIMITED
ROC-BANGALORE
ACTIVE
MANUFACTURE OF CHEMICALS AND CHEMICAL PRODUCTS
U24290KA2020PTC142000
09-DEC-2020
COMPANY LIMITED BY SHARES
NON-GOVT COMPANY
PRIVATE
100000
100000
CONTACT DETAILS
584102
INDIA
12-10-92/1, GANDHI CHOWK SRRNO 4554 R2 T8 P4/A LINGASUGUR RAICHUR KA 584102 IN
basavaajrm135@gmail.com
DIRECTOR DETAILS
DIN | Director Name | Designation | Appointment Date |
---|---|---|---|
08988946 | BASAVARAJ | Director | 09/12/2020 |
08988947 | RAVI KUMAR | Director | 09/12/2020 |
08988948 | SURESH | Director | 09/12/2020 |
Details Updated by Companies
Quick Links
- All Registered company of KARNATAKA
- Company Registered in KARNATAKA
- All Registered company of RAICHUR in KARNATAKA
- Listed Company
- Company Category
- Latest Registered Company
Contact Us for Update Extra Information about your company and services.